Change to refugee health care program puts Windsor clients at risk: Matthew House director
Windsor-Essex community members and experts say they are “panicking” that an upcoming new federal co-payment system will hurt access to healthcare for refugees and instead can increase overall costs.
https://www.cbc.ca/news/canada/windsor/canada-co-pay-system-refugee-care-devastating-9.7173297?cmp=rss
Advocates say changes to refugee health care program puts Ontario clients at risk
Windsor-Essex community members and experts say they are “panicking” that an upcoming new federal co-payment system will hurt access to healthcare for refugees and instead can increase overall costs.
https://www.cbc.ca/news/canada/windsor/canada-co-pay-system-refugee-care-devastating-9.7173297?cmp=rss
Canada hurting vulnerable refugee claimaints with new health-care fees, N.L. providers say
Members of the St. John's medical community are speaking out against a federal co-payment system they say will hurt access to care for refugees.
https://www.cbc.ca/news/canada/newfoundland-labrador/canada-co-pay-system-refugee-care-nl-9.7163471?cmp=rss
Dental Care Plan: 27,000 Canadians found ineligible, 43K will have higher co-payment

About one per cent of Canadian Dental Care Plan (CDCP) members have been found to be ineligible for the program, or have been assessed at an inaccurate co-payment level, Health Canada said on Tuesday.

CTVNews

A Bitter Battle Over the ‘Orphan Drug’ Program Leaves Patients’ Pocketbooks at Risk

A #prescription drug that helps Lore Wilkinson walk and talk despite a rare muscle disease cost her so little for more than a decade that she didn’t even use her insurance to pay for it. But now, her #Medicare #insurance is shelling out about $40,000 for a one-month supply of the drug, and she fears she’ll be slammed with a $9,000 #copayment. #Healthcare

https://khn.org/news/article/a-bitter-battle-over-the-orphan-drug-program-leaves-patients-pocketbooks-at-risk/

A Bitter Battle Over the ‘Orphan Drug’ Program Leaves Patients’ Pocketbooks at Risk

Patients who depend upon special drugs to treat rare diseases are caught in the crossfire as drugmakers and the FDA battle over regulations that reward companies for developing treatments for relat…

Kaiser Health News